Business Health

Fampyra API Insight 2019

Press Release

“Fampyra API Insight 2019” report by DelveInsight provides product and API manufacturers’ details across US, Europe, China and India for Fampyra . It includes Fampyra overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities. It further provides Fampyra ’s patents information (US & EU). It also features the historical and forecasted sales of Fampyra till 2021. The report also highlights Fampyra ’s market competition and emerging therapies which are in the same space as Fampyra .

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
• Patent information around Fampyra in United States (US) and Europe (EU) has been highlighted
• API manufacturers for Fampyra in United States, Europe, China and India
• The report contains historical and forecasted sales for Fampyra till 2021
• Enlists the market competition and emerging therapies in the space where Fampyra operates

Reasons to Buy
• Establish a comprehensive understanding of the drug, Fampyra
• Access to Fampyra ’s API manufacturers details to devise API procurement strategy for generic development
• Plan generic developmental timelines around Fampyra ’s patents for the major markets- US and EU
• Understand Fampyra ’s current and future growth through its historical and forecasted sales
• Identify the current in-market competitors for Fampyra
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify the emerging players and their products operating in the same space as Fampyra

Request for sample pages

Table of contents

1. Report Introduction
2. Fampyra Overview
• Product Description
• Mechanism of Action
• Dosage and Administration
• Pharmacodynamic Properties
• Pharmacokinetic Properties
• Safety and Efficacy of Fampyra
• Clinical Trial Description
• Adverse Reactions
• Product Development Activities
3. Product Details
• United States
• Europe
4. Fampyra Global Sales Assessment
• Historical Global Sales
• Forecasted Global Sales
5. Patent Details
6. Global API Manufacturers Assessment
• United States
• Europe
• China
• India
7. Market Competitors
8. Emerging Therapies
9. Appendix
• Methodology
• Consulting Services
• About DelveInsight

This post was originally published on The Market Plan